Ovarian cancer is often referred to as a “silent” disease, not because symptoms are absent, but because they are frequently subtle, non-specific, and easily mistaken for more common conditions. During Ovarian Cancer Awareness Month, increasing recognition of these symptoms is essential to support earlier clinical investigation and improve patient outcomes. Accurate and dependable in vitro diagnostic (IVD) testing plays a key role in this pathway, providing laboratories and clinicians with the reliable data needed to guide decision-making.

Why Symptom Awareness Is Important

Many patients experience symptoms for months before seeking medical advice. These symptoms are typically persistent rather than severe, which can delay further investigation. Greater awareness among healthcare professionals and patients helps ensure that ongoing or unusual changes prompt appropriate clinical assessment and laboratory testing.

Common Symptoms That Should Not Be Overlooked

Symptoms associated with ovarian cancer can include:

• Persistent abdominal bloating
• Pelvic or abdominal pain
• Feeling full quickly or loss of appetite
• Increased urinary urgency or frequency
• Unexplained fatigue or weight changes

While these symptoms are common in many benign conditions, their frequency, persistence, and change from normal are key factors that indicate the need for further evaluation.

The Link Between Symptom Recognition and Laboratory Testing

When symptoms raise clinical concern, laboratory investigation becomes an important next step in the diagnostic pathway. Biomarker testing can support risk assessment, patient triage, and ongoing monitoring.

For laboratories, this places significant importance on:

• High analytical accuracy
• Reproducible performance
• Standardised methodologies
• Robust quality control

Reliable results give clinicians greater confidence when making decisions about imaging, referral, or patient management.

The Role of High-Quality IVD Solutions

Consistent and accurate tumour marker measurement is essential in the assessment and monitoring of ovarian cancer risk. High-quality reagents, calibrators, and controls help ensure:

• Dependable performance across testing runs
• Reduced variability
• Confidence in longitudinal patient monitoring

This level of reliability is critical for laboratories handling increasing testing demands while maintaining strict quality standards.

Supporting Laboratories Worldwide

As a global provider of IVD solutions, Biorex Diagnostics supports laboratories with assays designed for consistent performance and reproducible results. By enabling accurate biomarker measurement, these solutions help laboratories deliver the high-quality data required for effective clinical evaluation and patient care.

Raising Awareness, Supporting Earlier Action

Improving recognition of ovarian cancer symptoms is a vital step towards earlier investigation. When combined with reliable laboratory diagnostics, this awareness helps create a stronger, more effective clinical pathway from first presentation to ongoing patient management.

Discover how Biorex IVD solutions support accurate and reliable tumour marker testing for ovarian cancer risk assessment here.